Thursday, June 20, 2019

How Artificial Intelligence Can Accelerate Drug Discovery

Artificial Intelligence has taken this world by storm, and medicine is no alien to the fact. From surgical robots to ingestible little bots, AI has firmly established its position to shape the future of the health sector. A fundamental shift is essential in the present paradigm in drug discovery, and artificial intelligence holds a clue to bring the pharmacy to a revolutionized new era. Can artificial intelligence discovers new drugs? Let’s find out.

Get Sample Insights



How AI helps in drug discovery process?

Current research is so vast that almost 10,000 publications are received daily, and it is humanly impossible to correlate, assimilate, and connect all data to produce a useful result. And we all know if it’s not done, a new hypothesis is equally difficult to create.

AI and machine learning had made it possible to gather data and analyze it first to extract “useful information” which is next under strict scrutiny of a panel of experts. Direct relationships between data and known facts are made, and unknown connections are founded. The validity of the proposed hypothesis is being judged by scientists and researchers and tested for the potential new mechanism of drug mechanism.

Apart from that, AI also offers mechanistic insight into a disease and provide new ways to tackle it. It can give an overall new target, and if used in “compound sense,” it allows us to tap into the larger chemical palette to pick our molecules. AI can also play a significant role in identifying any issues with security and efficacy with compounds much earlier than presently possible, thus saving time and resources which can be devoted to the cure of serious diseases. It can be used to build an affordable, sustainable and efficient pipeline of new medicines.

How AI and Drug Discovery are merging?

Artificial intelligence (AI) have successfully used in various areas, which include computer vision, speech recognition, and natural language processing. However, AI is now increasingly getting into the areas that need substantial domain expertise. The fields are biology, chemistry, and it also helps to lower the cost of drug discovery and drug development. Artificial intelligence is used in the drug discovery and development by growing the level of understanding of complex biology, managing drug design, and by assisting other more ordinary elements of pharmaceutical R&D and regulatory affairs. The application of AI decreases researches and development gap in the drug manufacturing process, and it helps in the targeted manufacturing of the drugs.




AI offers numerous benefits in the process of drug discovery and other developments. Some of the advantages of AI techniques include, it enhances the value of the product, makes the drug discovery faster, inexpensive, and more productive.

Download Sample PDF


Challenges in Machine Learning for Drug Discovery

Along with the various benefits offered by AI solutions in the drug discovery industry, there are also particular challenges. The safety of the drug is among the significant challenges faced in the drug discovery process. The information about the effects of drugs and calculating their side effects is a difficult job. Scientists and engineers from Roche and Pfizer are obtaining information from clinical data with the help of AI. Interpretation of this data in the context of drug safety is an active area of research.

The clinical trials are the most expensive stage of drug development. For reducing the costs, it is vital to use the previously gained experience of clinical trials in the early stages of drug development. The safety of the drug discovery is done in by the biomedical data from research experiments should be examined and interpreted with the help of machine learning for predicting a drug’s effects and side effects. And secondly, the data from clinical trials investigated with machine learning supports the explanation of biological data. The mentioned approaches have made it possible to design better preclinical experiments for the most effective therapies with minimal side effects. To decrease the risks associated with data storage, organizations have developed advanced AI systems that are capable of enhancing drug discovery.

No comments:

Post a Comment

Changes and Challenges in the Industrial Microbiology Market

The Industrial Microbiology market is anticipated to grow in the forecast, owing to the factors such as growing demand for nutraceuticals...

The Insight Partners